---
title: Leveraging Platform and Process Characterization Data to Accelerate CGT Validation and Commercialization
description: Discover how Viralgen’s high-throughput sequencing (HTS) technologies deliver precise rAAV product characterization, advancing gene therapy quality and compliance.
---

[Resources | Viralgen ](https://viralgen.com/resources)

# [Leveraging Platform and Process Characterization Data to Accelerate CGT Validation and Commercialization](https://viralgen.com/resources/leveraging-platform-and-process-characterization-data-to-accelerate-cgt-validation-and-commercialization)

 Written by [Viralgen](https://viralgen.com/resources/author/viralgen) | Oct 24, 2024 4:00:00 AM

Revolutionizing recombinant adeno-associated virus (rAAV) characterization, Viralgen’s poster presents how high-throughput sequencing (HTS) enables detailed insights into rAAV product integrity, identity, and purity. This innovative approach aligns with stringent quality requirements for advanced gene therapies.

**Key Highlights:**

- **In-depth Analysis:** Viralgen's HTS methodology evaluates DNA sequence integrity and fidelity, identifying truncations and off-target events with unparalleled precision.
- **Method Performance:** Their process demonstrates exceptional sensitivity and accuracy, paving the way for reliable analysis of rAAV preparations.
- **Regulatory Alignment:** These methods set a new benchmark for meeting critical quality attributes (CQAs), ensuring compliance with global standards.

By advancing analytical precision, Viralgen is empowering the development of safer, more effective gene therapies.

[View full post](https://viralgen.com/resources/leveraging-platform-and-process-characterization-data-to-accelerate-cgt-validation-and-commercialization)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Viralgen"
  },
  "dateModified" : "2025-01-17T14:18:20.712Z",
  "datePublished" : "2024-10-24T04:00:00Z",
  "headline" : "Leveraging Platform and Process Characterization Data to Accelerate CGT Validation and Commercialization",
  "image" : {
    "@type" : "ImageObject",
    "height" : 660,
    "url" : "https://viralgen.com/hubfs/Leveraging%20Platform%20and%20Process%20Characterization%20Data%20to%20Accelerate%20CGT%20Validation%20and%20Commercialization.png",
    "width" : 960
  },
  "mainEntityOfPage" : "https://viralgen.com/resources/leveraging-platform-and-process-characterization-data-to-accelerate-cgt-validation-and-commercialization",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "Resources | Viralgen"
  }
}
```